Cargando…

Epigenetic initiation of the T(H)17 differentiation program is promoted by Cxxc finger protein 1

IL-6/STAT3 signaling is known to initiate the T(H)17 differentiation program, but the upstream regulatory mechanisms remain minimally explored. Here, we show that Cxxc finger protein 1 (Cxxc1) promoted the generation of T(H)17 cells as an epigenetic regulator and prevented their differentiation into...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Feng, Meng, Xiaoyu, Guo, Yixin, Cao, Wenqiang, Liu, Wanlu, Xia, Qiming, Hui, Zhaoyuan, Chen, Jian, Hong, Shenghui, Zhang, Xuliang, Wu, Chuan, Wang, Di, Wang, Jianli, Lu, Linrong, Qian, Wenbin, Wei, Lai, Wang, Lie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785255/
https://www.ncbi.nlm.nih.gov/pubmed/31633019
http://dx.doi.org/10.1126/sciadv.aax1608
Descripción
Sumario:IL-6/STAT3 signaling is known to initiate the T(H)17 differentiation program, but the upstream regulatory mechanisms remain minimally explored. Here, we show that Cxxc finger protein 1 (Cxxc1) promoted the generation of T(H)17 cells as an epigenetic regulator and prevented their differentiation into T(reg) cells. Mice with a T cell–specific deletion of Cxxc1 were protected from experimental autoimmune encephalomyelitis and were more susceptible to Citrobacter rodentium infection. Cxxc1 deficiency decreased IL-6Rα expression and impeded IL-6/STAT3 signaling, whereas the overexpression of IL-6Rα could partially reverse the defects in Cxxc1-deficient T(H)17 cells in vitro and in vivo. Genome-wide occupancy analysis revealed that Cxxc1 bound to Il6rα gene loci by maintaining the appropriate H3K4me3 modification of its promoter. Therefore, these data highlight that Cxxc1 as a key regulator governs the balance between T(H)17 and T(reg) cells by controlling the expression of IL-6Rα, which affects IL-6/STAT3 signaling and has an impact on T(H)17-related autoimmune diseases.